CINF
51
4
CSX
57
6
NSC
57
7
PPG
60
3
GRMN
64
2
SRE
66
3
ALLE
44
7
TMO
47
3
BXP
52
2
BAX
30
4
AKAM
50
7
SWK
61
5
KR
38
4
EOG
56
-2
WEC
55
2
F
47
4
L
64
2
URBN
42
4
FLR
55
6
EXPD
45
8
CINF
51
4
CSX
57
6
NSC
57
7
PPG
60
3
GRMN
64
2
SRE
66
3
ALLE
44
7
TMO
47
3
BXP
52
2
BAX
30
4
AKAM
50
7
SWK
61
5
KR
38
4
EOG
56
-2
WEC
55
2
F
47
4
L
64
2
URBN
42
4
FLR
55
6
EXPD
45
8
Financhill
Back

Recursion Pharmaceuticals Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
44

RXRX
Recursion Pharmaceuticals

Last Price:
5.70
Seasonality Move:
6.36%
Sell
30

NBY
NovaBay Pharmaceuticals

Last Price:
0.69
Seasonality Move:
-0.57%
Sell
44
Recursion Pharmaceuticals (RXRX) is a Sell

Is Recursion Pharmaceuticals a Buy, Sell or Hold?

  • The current Recursion Pharmaceuticals [RXRX] share price is $5.75. The Score for RXRX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • RXRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.72. The Score for NBY is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RXRX Stock Price Chart

What is Recursion Pharmaceuticals's stock price today?

  • The Recursion Pharmaceuticals share price today is $5.75
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RXRX is experiencing slight selling pressure.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.72
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing buying pressure, which is a positive indicator for future bullish movement.

RXRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.13 Sell
Relative Strength Index (14 RSI): 37.1 Sell
Chaikin Money Flow: -4487806 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (6.21 - 7.15) Sell
Bollinger Bands (100): (6.27 - 7.63) Sell

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.02 Buy
Relative Strength Index (14 RSI): 54.51 Buy
Chaikin Money Flow: 23717 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.61 - 0.75) Buy
Bollinger Bands (100): (0.27 - 1.45) Sell

RXRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.52 Sell
20-day SMA: 6.7 Sell
50-day SMA: 6.63 Sell
200-day SMA: 8.34 Sell
8-day EMA: 6.34 Sell
20-day EMA: 6.58 Sell
50-day EMA: 6.71 Sell
200-day EMA: 7.7 Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.72 Sell
20-day SMA: 0.7 Buy
50-day SMA: 0.66 Buy
200-day SMA: 2.35 Sell
8-day EMA: 0.71 Buy
20-day EMA: 0.7 Buy
50-day EMA: 0.73 Sell
200-day EMA: 5.62 Sell

Recursion Pharmaceuticals Earnings Growth & RXRX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and a decrease next year of $0.11 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.

Recursion Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):